Hope builds for earlier detection of Alzheimer's disease (original) (raw)

New recommendations to change the diagnostic criteria for Alzheimer's disease and recent advances in biomarker development may allow earlier diagnosis of this disease, potentially providing key tools for drug development.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Learn more

Buy this article

• Purchase on SpringerLink
• Instant access to full article PDF

Buy now

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Authors

1. Alisa Opar
   View author publications
   You can also search for this author inPubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Opar, A. Hope builds for earlier detection of Alzheimer's disease.Nat Rev Drug Discov 9, 579–581 (2010). https://doi.org/10.1038/nrd3237

Download citation

• Issue Date: August 2010
• DOI: https://doi.org/10.1038/nrd3237

This article is cited by

• Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases

  • Daniel W. Neef
  • Alex M. Jaeger
  • Dennis J. Thiele
    Nature Reviews Drug Discovery (2011)

• Alzheimer's failure raises questions about disease-modifying strategies

  • Andy Extance
    Nature Reviews Drug Discovery (2010)